53 results
6-K
NTBL
Notable Labs Ltd
6 Jan 15
Current report (foreign)
12:00am
% or more of the voting rights in the Company or has the right to appoint the majority of the directors of the Company or its general manager. With respect … to certain matters, a controlling shareholder is deemed to include a person that holds 25% or more of the voting rights in our Company if no other
S-3
NTBL
Notable Labs Ltd
17 Oct 23
Shelf registration
5:01pm
-6. Our purpose as set forth in our amended and restated articles of association is to engage in any lawful activity.
Voting Rights and Conversion … do not have cumulative voting rights for the election of directors. As a result, the holders of a majority of the voting power present and voting
6-K
EX-99.2
4137u98t 9he676b5o
1 Nov 19
Current report (foreign)
4:15pm
6-K
EX-99.2
v34w9e0
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-99.2
nm9uuq5 0uehn4
28 May 20
Notice of Annual General Meeting of Shareholders
9:14am
6-K
EX-99.2
iv206khihanum4o1
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
F-3
ehfpjqm bm
30 Dec 20
Shelf registration (foreign)
4:17pm
6-K
kwzam
21 Apr 15
Current report (foreign)
12:00am
8-K
EX-3.1
uy1202g
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
DEF 14A
p0lmk11ppz29jbihgb
16 Feb 24
Definitive proxy
9:00am
PRE 14A
r8fip7h x9lgn
5 Feb 24
Preliminary proxy
5:00pm
6-K
EX-99.2
iwzmei
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
424B5
l06l922
27 Jun 18
Prospectus supplement for primary offering
9:30am
424B5
0zi1ld qt2j
11 May 20
Prospectus supplement for primary offering
9:23am
424B5
zw4jscdqjf73 f7xj5k
17 May 19
Prospectus supplement for primary offering
5:19pm
424B5
6iy5pyt3poawbsh7
15 Jan 21
Prospectus supplement for primary offering
7:00am
424B5
kdz miglg
11 Feb 22
Prospectus supplement for primary offering
5:28pm